Clinical Trials
4 trialsNCT00514371 2015-12-07
TIME-2
Bristol-Myers Squibb
Phase 2/3 Completed
NCT00303797 2013-03-19
Sorafenib and Bortezomib in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00546780 2011-06-28
BMS TIME-1
Bristol-Myers Squibb
Phase 3 Completed
NCT00113204 2008-05-20
IPi-504-01
Infinity Pharmaceuticals, Inc.
Phase 1 Completed